Insider Transactions in Q4 2023 at Cytosorbents Corp (CTSO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Alan D. Sobel Director |
BUY
Open market or private purchase
|
Direct |
22,557
+18.13%
|
$22,557
$1.33 P/Share
|
|
Dec 13
2023
|
Phillip P. Chan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
75,188
+6.57%
|
$75,188
$1.33 P/Share
|
|
Dec 13
2023
|
Jiny Kim Director |
BUY
Open market or private purchase
|
Direct |
7,519
+8.81%
|
$7,519
$1.33 P/Share
|
|
Dec 13
2023
|
Kathleen P. Bloch Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
37,594
+7.44%
|
$37,594
$1.33 P/Share
|
|
Dec 13
2023
|
Edward Raymond Jones Director |
BUY
Open market or private purchase
|
Direct |
7,519
+7.8%
|
$7,519
$1.33 P/Share
|
|
Dec 13
2023
|
Michael G. Bator Director |
BUY
Open market or private purchase
|
Direct |
37,594
+23.07%
|
$37,594
$1.33 P/Share
|
|
Dec 13
2023
|
Vincent Capponi President and COO |
BUY
Open market or private purchase
|
Direct |
18,797
+3.12%
|
$18,797
$1.33 P/Share
|
|
Dec 13
2023
|
Efthymios Deliargyris Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
22,557
+6.08%
|
$22,557
$1.33 P/Share
|